No need for secondary <i>Pneumocystis jirovecii</i> pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL
Andrew Atkinson, Hansjakob Furrer(University of Bern), Jade Ghosn(Délégation Paris 5), Christoph Stephan(Goethe University Frankfurt), David Kraus(University of Bern), De Wit S(Université Libre de Bruxelles), Anastasia Antoniadou(National and Kapodistrian University of Athens), Amanda Mocroft(University of Copenhagen), Enrico Girardi(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Cristina Mussini(University of Modena and Reggio Emilia), Katja Doerholt(St George's Hospital), Marcel Zwahlen(University of Bern), Philippe Morlat(Centre Hospitalier Universitaire de Bordeaux), Peter Reiss(Amsterdam Institute for Global Health and Development), José M. Miró(Hospital Clínic de Barcelona), Ole Kirk(University of Copenhagen)
Cited by 17
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
|The Lancet|2007|1.4k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2008|1k